Polyseq Biotech

Private

BeijingHealthcare & Life Scienceshttps://polyseq.com/

Last Round

Series B

Mar 16, 2026

Total Funding Raised

$14.37M

Company Overview

Polyseq Biotech is a biotechnology company that develops and manufactures nanopore-based gene sequencing platforms, including sequencers, biochips, and reagents.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

genomic sequencingnext-generation sequencingNGSnanopore sequencingmolecular diagnosticsDNA sequencingRNA sequencingbasecallinggenomics AIbiotech hardwareprecision medicinegenomic datasequencing consumablesbioinformatics toolsrazor-and-blade model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Polyseq Biotech Comps

Public and private peers based on sector, stage, and business model.

Polyseq Biotech comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Polyseq Biotech Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Mar 16, 2026
Series A	May 12, 2023
Angel	Jan 7, 2022

View all Funding Rounds

Polyseq Biotech Investors

Notable investors and investment history

Polyseq Biotech investors
Investor	Rounds
Beijing Chang Development	Series B
IDG Capital	Series A, Series B, Angel
CAS Venture Capital	Series B
Guangzhou Sanmei Investment Management Center (Limited Partnership)	Series A
BOC Capital Investment Holdings Co., Ltd.	Series B
Tsinghua Innovation Ventures	Series A, Angel
Beijing Shangshi Investment Management	Series A

View all Investors

Polyseq Biotech Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Polyseq Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Polyseq Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing

Year Founded2021

Last FundingMar 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.